August 22, 2025

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and III Colorectal Cancer

In a Korean retrospective study reported in JAMA Network Open, Bong et al found that the addition of oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy was associated with a survival benefit ...

The ASCO Post

August 22, 2025

Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

In a phase II study (ENGOT-OV60/GOG-3052/RAMP 201) reported in the Journal of Clinical Oncology, Banerjee et al evaluated the efficacy and safety of the RAF/MEK clamp avutometinib in combination with ...

The ASCO Post

August 22, 2025

Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma

The randomized phase III C-POST trial attempted to learn whether the standard-of-care treatment in advanced cutaneous squamous cell carcinoma—cemiplimab-rwlc, which blocks the PD-1/PD-L1 pathway—could...

The ASCO Post

August 22, 2025

Updated CHEST Guidelines Emphasize Minimally Invasive Surgery for Early-Stage NSCLC

Updated clinical guidelines for the management of patients with early-stage non–small cell lung cancer (NSCLC) from the American College of Chest Physicians (CHEST) recommend use of more minimally inv...

The ASCO Post

August 15, 2025

Nivolumab Added to Chemoradiotherapy Reduced Recurrence Risk in High-Risk Head and Neck Cancer

Adding the PD-1 inhibitor nivolumab to standard chemoradiotherapy after surgery significantly reduced recurrence rates for patients with locally advanced head and neck squamous cell carcinoma who are ...

The ASCO Post

August 14, 2025

Why Sarcomas Require Expert, Multidisciplinary Cancer Care

Sarcomas are one of the rarest and most complex cancer types, making up less than 1% of all new cancer diagnoses in the United States.

Baptist Health South Florida

August 07, 2025

Laser-Induced Polymer Fragmentation in IOLs

Even with the finest skills, technique, devices and experience, performance suffers when clarity is compromised

The Ophthalmologist

August 06, 2025

SCHWIND PresbyMAX: A Universe of Possibilities

Enhancing outcomes in presbyopic laser vision correction

The Ophthalmologist

July 30, 2025

Pancreatic Cancer Survival Linked to Ki-67 Index

Researchers evaluate prognostic features in 904 patients with surgically resected pancreatic neuroendocrine tumors

The Pathologist